tiprankstipranks
Trending News
More News >
ChemoMetec A/S (DE:CHY)
FRANKFURT:CHY
Germany Market

ChemoMetec A/S (CHY) Ratios

Compare
4 Followers

ChemoMetec A/S Ratios

DE:CHY's free cash flow for Q2 2025 was kr0.92. For the 2025 fiscal year, DE:CHY's free cash flow was decreased by kr and operating cash flow was kr0.50. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
4.00 4.13 2.57 3.40 3.53
Quick Ratio
2.92 3.19 2.08 2.98 3.00
Cash Ratio
2.16 2.66 1.52 2.09 2.03
Solvency Ratio
1.35 1.54 1.20 1.27 1.15
Operating Cash Flow Ratio
1.44 1.29 1.29 1.50 1.51
Short-Term Operating Cash Flow Coverage
144.67 152.47 172.55 182.27 169.85
Net Current Asset Value
kr 358.69Mkr 367.73Mkr 208.87Mkr 164.43Mkr 107.90M
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.01 0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 0.01 0.02 <0.01 0.01
Debt-to-Capital Ratio
0.01 0.01 0.02 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.22 1.23 1.40 1.30 1.30
Debt Service Coverage Ratio
138.47 92.28 68.76 69.29 46.60
Interest Coverage Ratio
0.00 211.91 133.72 126.39 65.16
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.45 0.47 0.48 0.19 0.21
Net Debt to EBITDA
-1.17 -1.26 -0.93 -1.15 -1.03
Profitability Margins
Gross Profit Margin
91.07%88.97%89.70%90.12%90.57%
EBIT Margin
45.77%52.08%47.78%40.43%38.05%
EBITDA Margin
47.87%55.22%51.01%45.89%42.94%
Operating Profit Margin
48.79%51.88%47.35%41.27%36.18%
Pretax Profit Margin
47.96%51.84%47.44%40.10%35.46%
Net Profit Margin
36.79%40.20%37.23%31.43%27.63%
Continuous Operations Profit Margin
36.79%40.20%37.23%31.43%27.63%
Net Income Per EBT
76.71%77.56%78.47%78.37%77.93%
EBT Per EBIT
98.31%99.91%100.18%97.16%98.00%
Return on Assets (ROA)
23.15%27.15%31.81%25.62%22.49%
Return on Equity (ROE)
29.07%33.52%44.64%33.34%29.18%
Return on Capital Employed (ROCE)
36.90%42.79%55.75%42.51%35.96%
Return on Invested Capital (ROIC)
28.17%32.97%43.51%33.14%27.88%
Return on Tangible Assets
28.32%30.89%36.75%30.78%27.94%
Earnings Yield
1.98%2.20%1.21%0.60%1.11%
Efficiency Ratios
Receivables Turnover
5.40 8.11 6.16 4.49 4.83
Payables Turnover
2.23 2.79 2.59 3.19 2.39
Inventory Turnover
0.31 0.44 0.66 0.92 0.80
Fixed Asset Turnover
4.38 5.37 5.73 6.62 4.94
Asset Turnover
0.63 0.68 0.85 0.82 0.81
Working Capital Turnover Ratio
1.21 1.51 2.21 1.92 1.94
Cash Conversion Cycle
1.08K 753.16 470.80 362.52 377.34
Days of Sales Outstanding
67.59 45.03 59.25 81.34 75.59
Days of Inventory Outstanding
1.18K 838.83 552.32 395.61 454.16
Days of Payables Outstanding
163.69 130.70 140.77 114.43 152.41
Operating Cycle
1.25K 883.86 611.57 476.95 529.75
Cash Flow Ratios
Operating Cash Flow Per Share
10.13 8.86 10.16 6.20 4.27
Free Cash Flow Per Share
8.75 6.51 6.95 4.79 2.69
CapEx Per Share
1.38 2.35 3.21 1.41 1.59
Free Cash Flow to Operating Cash Flow
0.86 0.74 0.68 0.77 0.63
Dividend Paid and CapEx Coverage Ratio
1.88 3.78 1.41 2.13 0.19
Capital Expenditure Coverage Ratio
7.33 3.78 3.16 4.38 2.69
Operating Cash Flow Coverage Ratio
22.66 21.53 26.03 45.76 31.43
Operating Cash Flow to Sales Ratio
0.38 0.35 0.41 0.38 0.34
Free Cash Flow Yield
1.78%1.40%0.92%0.57%0.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
50.42 45.39 82.61 166.14 89.75
Price-to-Sales (P/S) Ratio
18.56 18.25 30.75 52.21 24.80
Price-to-Book (P/B) Ratio
14.26 15.21 36.88 55.40 26.19
Price-to-Free Cash Flow (P/FCF) Ratio
56.04 71.56 108.92 176.26 117.27
Price-to-Operating Cash Flow Ratio
48.39 52.61 74.49 136.04 73.74
Price-to-Earnings Growth (PEG) Ratio
2.10 3.75 1.03 3.71 2.94
Price-to-Fair Value
14.26 15.21 36.88 55.40 26.19
Enterprise Value Multiple
37.60 31.79 59.36 112.64 56.74
Enterprise Value
EV to EBITDA
37.60 31.79 59.36 112.64 56.74
EV to Sales
18.00 17.55 30.28 51.69 24.36
EV to Free Cash Flow
54.35 68.83 107.25 174.49 115.18
EV to Operating Cash Flow
46.94 50.60 73.34 134.67 72.42
Tangible Book Value Per Share
26.71 26.05 16.65 11.90 8.98
Shareholders’ Equity Per Share
34.37 30.63 20.53 15.23 12.03
Tax and Other Ratios
Effective Tax Rate
0.23 0.22 0.22 0.22 0.22
Revenue Per Share
26.41 25.54 24.62 16.15 12.70
Net Income Per Share
9.72 10.27 9.16 5.08 3.51
Tax Burden
0.77 0.78 0.78 0.78 0.78
Interest Burden
1.05 1.00 0.99 0.99 0.93
Research & Development to Revenue
<0.01 0.01 0.01 0.02 0.03
SG&A to Revenue
0.00 0.00 0.10 0.08 0.12
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.04 0.67 0.87 0.93 0.93
Currency in DKK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis